<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39374995</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2530-0180</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Endocrinologia, diabetes y nutricion</Title><ISOAbbreviation>Endocrinol Diabetes Nutr (Engl Ed)</ISOAbbreviation></Journal><ArticleTitle>Increased incidence of pediatric type 1 diabetes during the pandemic in Biscay, Spain.</ArticleTitle><Pagination><StartPage>332</StartPage><EndPage>339</EndPage><MedlinePgn>332-339</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.endien.2024.09.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2530-0180(24)00095-7</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To update the incidence rate (IR) and trends of type 1 diabetes mellitus (T1DM) in children aged 0-14 years from 2003 to 2022, in Biscay, Spain.</AbstractText><AbstractText Label="SUBJECTS AND METHOD" NlmCategory="METHODS">We used the capture-recapture method: primary cases were prospectively extracted from the hospital registry and a secondary independent data source was obtained from diabetes associations and a public health database. The IRs standardized by age and sex were calculated using the direct method, assuming an equal distribution in each age/sex group. The IR occurring during the various COVID-19 waves was compared with the pre-pandemic IR.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 378 new cases were identified. The mean age at diagnosis was 9.7 years (5.8-11.9). The completeness of ascertainment was 99.1%. The mean annual age-standardized IR was 12.92 (95%CI, 11.35-13.91). The mean IRs for the 0-4, 5-9, and 10-14 age groups were 7.67, 13.41 and 17.83 cases/100,000 children/year, respectively. The IR trend was statistically significant in the entire group and in the 5-9 year-old group with a mean annual increase of 1.9% (95%CI, 0.1-3.8) and 3.3% (95%CI, 1.002-1.065); p=0.039. The 5-year period analysis confirmed that the increase was significant only in the last 5 years (20%). When 2020-2022 (pandemic) and 2017-2019 (pre-pandemic) periods were compared this difference goes up to 44.5%; p=0.029.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">After a long period of stability in the IR of T1DM in children younger than 15 years of age in Biscay, Spain, an increase in recent years has been reported, which is consistent with the SARS-CoV2 pandemic, with the largest increase being reported in the 5-to 9-year-old age group.</AbstractText><CopyrightInformation>Copyright © 2024 SEEN and SED. Published by Elsevier España, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fernández-Ramos</LastName><ForeName>Concepción</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Pediatric Endocrinology Unit, Biobizkaia Health Research Institute, Basurto University Hospital, University of the Basque Country (UPV/EHU), Avenida Montevideo 18, 48013 Bilbao, Bizkaia, Spain. Electronic address: conchi.fernandezramos@osakidetza.eus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arana-Arri</LastName><ForeName>Eunate</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Clinical Epidemiology Unit, Biobizkaia Health Research Institute, Cruces University Hospital, Plaza de Cruces s/n, 48903 Barakaldo, Bizkaia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vela</LastName><ForeName>Amaia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pediatric Endocrinology Unit, Biobizkaia Health Research Institute, Cruces University Hospital, University of the Basque Country (UPV/EHU), CIBERDEM, Plaza de Cruces s/n, 48903 Barakaldo, Bizkaia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urrutia</LastName><ForeName>Inés</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Biobizkaia Health Research Institute, CIBERDEM, CIBERER, University of the Basque Country (UPV/EHU), Endo-ERN, Plaza de Cruces s/n, 48903 Barakaldo, Bizkaia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos Zorrozua</LastName><ForeName>Borja</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Bioinformatics, Biostatistics and Information Systems Unit, Biobizkaia Health Research Institute, Plaza de Cruces s/n, 48903 Barakaldo, Bizkaia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rica</LastName><ForeName>Itxaso</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Pediatric Endocrinology Unit, Biobizkaia Health Research Institute, Cruces University Hospital, CIBERDEM, CIBERER, Plaza de Cruces s/n, 48903 Barakaldo, Bizkaia, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Endocrinol Diabetes Nutr (Engl Ed)</MedlineTA><NlmUniqueID>101717565</NlmUniqueID><ISSNLinking>2530-0180</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Diabetes mellitus tipo 1</Keyword><Keyword MajorTopicYN="N">Epidemiologia</Keyword><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Incidence rate</Keyword><Keyword MajorTopicYN="N">Incidence trend</Keyword><Keyword MajorTopicYN="N">Incidencia</Keyword><Keyword MajorTopicYN="N">Tendencia en incidencia</Keyword><Keyword MajorTopicYN="N">Type 1 diabetes mellitus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>4</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>20</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39374995</ArticleId><ArticleId IdType="doi">10.1016/j.endien.2024.09.002</ArticleId><ArticleId IdType="pii">S2530-0180(24)00095-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle>